Jiangsu Jibeier Pharmaceutical Co., Ltd.

SHSE:688566 Stok Raporu

Piyasa değeri: CN¥4.7b

Jiangsu Jibeier Pharmaceutical Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Jiangsu Jibeier Pharmaceutical has been growing earnings at an average annual rate of 19%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 13.3% per year. Jiangsu Jibeier Pharmaceutical's return on equity is 10.5%, and it has net margins of 26.9%.

Anahtar bilgiler

19.0%

Kazanç büyüme oranı

13.7%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi10.9%
Gelir büyüme oranı13.3%
Özkaynak getirisi10.5%
Net Marj26.9%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Impressive Earnings May Not Tell The Whole Story For Jiangsu Jibeier Pharmaceutical (SHSE:688566)

May 02
Impressive Earnings May Not Tell The Whole Story For Jiangsu Jibeier Pharmaceutical (SHSE:688566)

Recent updates

Even With A 38% Surge, Cautious Investors Are Not Rewarding Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (SHSE:688566) Performance Completely

Oct 08
Even With A 38% Surge, Cautious Investors Are Not Rewarding Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (SHSE:688566) Performance Completely

Does Jiangsu Jibeier Pharmaceutical (SHSE:688566) Deserve A Spot On Your Watchlist?

Oct 01
Does Jiangsu Jibeier Pharmaceutical (SHSE:688566) Deserve A Spot On Your Watchlist?

Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (SHSE:688566) Shares Lagging The Market But So Is The Business

Jul 30
Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (SHSE:688566) Shares Lagging The Market But So Is The Business

Impressive Earnings May Not Tell The Whole Story For Jiangsu Jibeier Pharmaceutical (SHSE:688566)

May 02
Impressive Earnings May Not Tell The Whole Story For Jiangsu Jibeier Pharmaceutical (SHSE:688566)

Gelir ve Gider Dağılımı

Jiangsu Jibeier Pharmaceutical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SHSE:688566 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 2488723947545
30 Jun 2487624545945
31 Mar 2489023447257
31 Dec 2386121946756
30 Sep 2384523043755
30 Jun 2381620943855
31 Mar 2368116437557
31 Dec 2265515536255
30 Sep 2256911833747
30 Jun 2251610131541
31 Mar 2252811731631
31 Dec 2151011530329
30 Sep 2153012730934
30 Jun 2157414033334
31 Mar 2157013233234
31 Dec 2056613033034
30 Sep 2054311831032
30 Jun 2053011030137
31 Mar 2053111430231
31 Dec 1954311331131
31 Dec 184859728420
31 Dec 174527826817
31 Dec 164447726617

Kaliteli Kazançlar: 688566 has high quality earnings.

Büyüyen Kar Marjı: 688566's current net profit margins (26.9%) are lower than last year (27.3%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 688566's earnings have grown by 19% per year over the past 5 years.

Büyüme Hızlandırma: 688566's earnings growth over the past year (3.5%) is below its 5-year average (19% per year).

Kazançlar vs. Sektör: 688566 earnings growth over the past year (3.5%) exceeded the Pharmaceuticals industry -1.2%.


Özkaynak Getirisi

Yüksek ROE: 688566's Return on Equity (10.5%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin